UB Paderborn / Katalog / Suche / in CDI

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

Trends in immunology, 2018-03, Vol.39 (3), p.209-221

2018

Volltextzugriff (PDF)

NAD+ salvage pathway in cancer metabolism and therapy

Pharmacological research, 2016-12, Vol.114, p.274-283

2016

Volltextzugriff (PDF)

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines

Frontiers in immunology, 2017-07, Vol.8, p.800-800

2017

Volltextzugriff (PDF)

The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis

Cell reports (Cambridge), 2018-08, Vol.24 (9), p.2381-2391.e5

2018

Volltextzugriff (PDF)

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

Oncoimmunology, 2020-01, Vol.9 (1), p.1794424-1794424

2020

Volltextzugriff (PDF)

After virus exposure, early bystander naïve CD8 T cell activation relies on NAD + salvage metabolism

Frontiers in immunology, 2023-02, Vol.13, p.1047661-1047661

2023

Volltextzugriff (PDF)

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Acta neuropathologica communications, 2018-01, Vol.6 (1), p.4-4, Article 4

2018

Volltextzugriff (PDF)

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy

Viruses, 2015-12, Vol.7 (12), p.6506-6525

2015

Volltextzugriff (PDF)

Newly Recruited CD11b+, GR-1+, Ly6Chigh Myeloid Cells Augment Tumor-Associated Immunosuppression Immediately following the Therapeutic Administration of Oncolytic Reovirus

The Journal of immunology (1950), 2015-05, Vol.194 (9), p.4397-4412

2015

Volltextzugriff (PDF)

Effect of waveform and brightness on display flicker perception

Journal of vision (Charlottesville, Va.), 2022-12, Vol.22 (14), p.3862

2022

Volltextzugriff (PDF)

Autophagic homeostasis is required for the pluripotency of cancer stem cells

Autophagy, 2017-02, Vol.13 (2), p.264-284

2017

Volltextzugriff (PDF)

P‐169: Late‐News Poster: How Display Size and Response time Affect flicker perception: Compare to flicker indices

SID International Symposium Digest of technical papers, 2023-06, Vol.54 (1), p.1708-1711

2023

Volltextzugriff (PDF)

Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities

Molecular & cellular proteomics, 2022-02, Vol.21 (2), p.100182-100182, Article 100182

2022

Volltextzugriff (PDF)

MHC‑I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T‑Cell Immunotherapies

Journal of proteome research, 2017-04, Vol.16 (4), p.1806-1816

2017

Volltextzugriff (PDF)

Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion

Stem cells (Dayton, Ohio), 2018-05, Vol.36 (5), p.641-654

2018

Volltextzugriff (PDF)

Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (15), p.3824-3836

2019

Volltextzugriff (PDF)

Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin

Analytical chemistry (Washington), 2019-04, Vol.91 (8), p.5106-5115

2019

Volltextzugriff (PDF)

Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy

Journal of proteome research, 2019-06, Vol.18 (6), p.2666-2675

2019

Volltextzugriff (PDF)

Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M‑CSF-Differentiated Bone Marrow-Derived Cells

Journal of proteome research, 2020-02, Vol.19 (2), p.708-718

2020

Volltextzugriff (PDF)

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus

The Journal of immunology (1950), 2015-05, Vol.194 (9), p.4397-4412

2015

Volltextzugriff (PDF)

Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages

Journal of proteome research, 2017-09, Vol.16 (9), p.3391-3406

2017

Volltextzugriff (PDF)

Francisella tularensis uses cholesterol and clathrin-based endocytic mechanisms to invade hepatocytes

Scientific reports, 2011-12, Vol.1 (1), p.192-192, Article 192

2011

Volltextzugriff (PDF)

All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy

Oncoimmunology, 2016-01, Vol.5 (1), p.e1057674-e1057674

2016

Volltextzugriff (PDF)

Francisella enters host cells by Clathrin‐mediated endocytosis at a cholesterol rich domain

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

NAD+ salvage pathway in cancer metabolism and therapy

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines

The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

After virus exposure, early bystander naïve CD8 T cell activation relies on NAD + salvage metabolism

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy

Newly Recruited CD11b+, GR-1+, Ly6Chigh Myeloid Cells Augment Tumor-Associated Immunosuppression Immediately following the Therapeutic Administration of Oncolytic Reovirus

Effect of waveform and brightness on display flicker perception

Autophagic homeostasis is required for the pluripotency of cancer stem cells

P‐169: Late‐News Poster: How Display Size and Response time Affect flicker perception: Compare to flicker indices

Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities

MHC‑I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T‑Cell Immunotherapies

Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion

Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus

Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin

Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma

Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M‑CSF-Differentiated Bone Marrow-Derived Cells

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus

Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages

Francisella tularensis uses cholesterol and clathrin-based endocytic mechanisms to invade hepatocytes

All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy

Francisella enters host cells by Clathrin‐mediated endocytosis at a cholesterol rich domain

Suchergebnisse filtern